Tomas Deierborg

Tomas Deierborg is a Professor and Research Team Manager at Neuroinflammation, Lund University. He serves as Principal Investigator for MultiPark: Multidisciplinary research focused on Parkinson's disease and Head of Department at the Department of Experimental Medical Science. Additionally, he is a Profile Area Member in Proactive Ageing and Affiliated Researcher at Infect@LU.

His research focuses on neuroinflammation, Alzheimer's disease, Parkinson's disease, and microglial function. Specific interests include protein aggregate transmission, galectin-3 mechanisms, gut-brain axis, and neuroimmune regulation. He explores amyloid-beta pathology, neuronal death pathways, and microglial polarization in neurodegenerative contexts.

Recent publications analyze CSF biomarker changes in Alzheimer's models, microglial extracellular vesicles in neuroinflammation, and galectin-3's role in pro-tumoral microglia. His work also addresses prion-like transmission of protein aggregates and immune modulatory therapies for neurodegenerative diseases.

Currently leading projects include "Denominating genetic and immunogenic factors of consequential microglia phenotype in AD", "Microglial Galectin-3 in Alzheimer's", and "Gut-brain axis in Alzheimer's disease". These projects receive funding from organizations like Alzheimerfonden and Swedish Research Council.

He collaborates internationally on neurodegenerative research, with affiliations to MultiPark and Infect@LU. Recent activities include research supervision workshops and translational studies connecting neuroimmunology to UN Sustainable Development Goals related to health and well-being.